Paradigm Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,000
| Closed | -$1.05M | – | 565 |
|
2024
Q3 | $1.05M | Hold |
1,000
| – | – | 0.28% | 158 |
|
2024
Q2 | $1.05M | Hold |
1,000
| – | – | 0.29% | 150 |
|
2024
Q1 | $962K | Hold |
1,000
| – | – | 0.24% | 179 |
|
2023
Q4 | $878K | Hold |
1,000
| – | – | 0.23% | 190 |
|
2023
Q3 | $823K | Hold |
1,000
| – | – | 0.23% | 189 |
|
2023
Q2 | $719K | Buy |
1,000
+700
| +233% | +$503K | 0.19% | 207 |
|
2023
Q1 | $247K | Hold |
300
| – | – | 0.07% | 265 |
|
2022
Q4 | $216K | Sell |
300
-1,000
| -77% | -$721K | 0.06% | 281 |
|
2022
Q3 | $896K | Hold |
1,300
| – | – | 0.3% | 104 |
|
2022
Q2 | $768K | Buy |
1,300
+300
| +30% | +$177K | 0.24% | 164 |
|
2022
Q1 | $698K | Hold |
1,000
| – | – | 0.18% | 195 |
|
2021
Q4 | $632K | Hold |
1,000
| – | – | 0.16% | 221 |
|
2021
Q3 | $605K | Sell |
1,000
-100
| -9% | -$60.5K | 0.17% | 227 |
|
2021
Q2 | $614K | Hold |
1,100
| – | – | 0.16% | 248 |
|
2021
Q1 | $520K | Hold |
1,100
| – | – | 0.14% | 260 |
|
2020
Q4 | $531K | Buy |
1,100
+100
| +10% | +$48.3K | 0.15% | 248 |
|
2020
Q3 | $560K | Hold |
1,000
| – | – | 0.17% | 234 |
|
2020
Q2 | $624K | Buy |
+1,000
| New | +$624K | 0.19% | 223 |
|
2019
Q2 | – | Sell |
-150
| Closed | -$61.6K | – | 418 |
|
2019
Q1 | $61.6K | Sell |
150
-50
| -25% | -$20.5K | 0.02% | 349 |
|
2018
Q4 | $74.7K | Sell |
200
-100
| -33% | -$37.4K | 0.02% | 324 |
|
2018
Q3 | $121K | Hold |
300
| – | – | 0.03% | 313 |
|
2018
Q2 | $103K | Hold |
300
| – | – | 0.03% | 314 |
|
2018
Q1 | $103K | Hold |
300
| – | – | 0.03% | 315 |
|
2017
Q4 | $113K | Sell |
300
-100
| -25% | -$37.6K | 0.03% | 311 |
|
2017
Q3 | $179K | Hold |
400
| – | – | 0.05% | 290 |
|
2017
Q2 | $196K | Hold |
400
| – | – | 0.04% | 347 |
|
2017
Q1 | $155K | Buy |
+400
| New | +$155K | 0.03% | 426 |
|
2013
Q4 | – | Sell |
-780
| Closed | -$244K | – | 838 |
|
2013
Q3 | $244K | Hold |
780
| – | – | 0.04% | 456 |
|
2013
Q2 | $175K | Buy |
+780
| New | +$175K | 0.03% | 475 |
|